TOP > News Releases

News Releases

June 14, 2018
Otsuka Pharmaceutical Factory launches the antiseptics for external use “Olanedine Antiseptic Solution OR”
June 5, 2018
Otsuka Pharmaceutical Factory launches a new Racol-NF Liquid for Enteral Use (for feeding tube and oral administration), green tea flavor
April 27, 2018
Otsuka Pharmaceutical Factory acquires all the shares of Lilium Otsuka held by Otsuka Medical Devices, making it a whollyowned subsidiary
March 20, 2018
Otsuka Pharmaceutical Factory enters into an agreement to acquire additional equity in its joint venture subsidiary, Otsuka Pharmaceutical India Private Limited, making it a wholly owned subsidiary
February 26, 2018
Otsuka Pharmaceutical Factory receives “Platinum Kurumin” certification as excellent company providing childcare support
February 21, 2018
Otsuka Pharmaceutical Factory certified as Excellent Health and Productivity Management Enterprise 2018
January 25, 2018
Otsuka Pharmaceutical Factory enters into an agreement to acquire additional equity in New Zealand joint venture company, Diatranz Otsuka Limited
January 19, 2018
Otsuka Signs Statement of Support for Women’s Empowerment Principles
December 25, 2017
Otsuka to invest in Megakaryon Corporation, with the aim to advance commercialization of iPS-cell-derived platelet preparations
September 21, 2017
Otsuka Pharmaceutical Factory completes acquisition of additional equity in its joint venture subsidiary, Otsuka Pharmaceutical India Private Limited
August 24, 2017
Otsuka Pharmaceutical Factory obtains import drug license of Cefazolin Sodium for Injection/Sodium Chloride Injection in China
August 23, 2017
Otsuka OPV, the Vietnamese subsidiary of Otsuka Pharmaceutical Factory announces the construction of a new factory for the distribution of high quality IV solution products
June 16, 2017
Otsuka Pharmaceutical Factory launches in Japan the anti-gastritis and anti-gastric ulcer agent "Rebamipide Tablets 100mg Otsuka"
May 9, 2017
Otsuka Pharmaceutical Factory enters into an agreement to acquire additional equity in its joint venture subsidiary, Otsuka Pharmaceutical India Private Limited (OPI)
November 25, 2016
Otsuka joins UN Global Compact
July 5, 2016
Otsuka Pharmaceutical Factory obtained the manufacturing and marketing approval of "ELNEOPA-NF No. 1 Injection and ELNEOPA-NF No. 2 Injection”
May 10, 2016
Otsuka Pharmaceutical Factory and Lilium Otsuka sign Japanese-market sales partnership agreement for the medical device “Lilium α-200"
March 2, 2016
Otsuka Pharmaceutical Factory changes the flavor and packaging of its Oral Rehydration Solution “OS-1"
September 16, 2015
Otsuka Pharmaceutical Factory launches the antiseptics for external use “Olanedine"
August 19, 2015
Otsuka Pharmaceutical Factory announces changes in the packaging container and volume of “Oronine H Ointment" (from now available in an 11-g tube size)
July 6, 2015
Otsuka Pharmaceutical Factory obtained the marketing approval of antiseptics for external use “Olanedine"
October 10, 2014
Otsuka Pharmaceutical Factory enters into a license agreement on bioengineered pancreatic islet “DIABECELL" as a treatment for diabetes
September 5, 2014
Otsuka Pharmaceutical Factory announces “PROCESS LEAD", a chew and swallow managing food
July 9, 2014
J.O.Pharma Co., Ltd. to expand its production facility in Izumo City
June 17, 2014
Egypt Otsuka acquires an Egyptian intravenous infusion manufacturing and distribution company.
June 16, 2014
Otsuka Pharmaceutical Factory announces personnel changes
June 2, 2014
Otsuka Pharmaceutical Factory launches “RACOL-NF Semi Solid for Enteral Use”
February 24, 2014
Otsuka Pharmaceutical Factory announces “HINE E-GEL" concentrated liquid nutrition product
October 25, 2013
Otsuka Pharmaceutical Factory launches a newly approved plasma substitute “Voluven 6%"
July 29, 2013
Otsuka Techno takes an equity interest in a Chinese firm that manufactures and markets plastic caps for IV solution-related products
May 22, 2013
Otsuka Pharmaceutical Factory and Fresenius Kabi Japan enter into an exclusive distribution agreement of HES products, including the newly approved “Voluven 6%"
December 7, 2012
Otsuka Pharmaceutical Factory and Mitsui enter into IV solutions business in India
December 14, 2011
Otsuka Techno to construct new factory at industrial park in Naruto, Tokushima
November 28, 2011
J.O. Pharma Co., Ltd. to construct a new manufacturing facility for prefilled syringes (a syringe with injectable drug solution filled in advance): Signing of an agreement with Shimane Prefecture and Izumo City for the facility construction
April 12, 2011
Otsuka Pharmaceutical Factory invests in Living Cell Technologies Limited, a biotechnology company advancing development of encapsulated porcine pancreatic islet replacement treatment
January 28, 2011
Otsuka Techno and Otsuka Pharmaceutical Factory take an equity interest in a Chinese firm that manufactures and markets plastic film for IV solution bags